Skip to content
10-Q

Quarterly Report

ANIXA BIOSCIENCES, INC. ANIX

0001493152-25-013000

← back to feed
Filed
Sep 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Sep 10, 2025 32.92M sh
Stock Issued Q3 2025 · Jul 31, 2025 611.69K sh
Shares Diluted Q3 2025 · Jul 31, 2025 32.48M sh
Shares Diluted Q3 2025 · Jul 31, 2025 32.29M sh
Shares Diluted restated Q3 2025 · Jul 31, 2024 32.05M sh
Shares Diluted restated Q3 2025 · Jul 31, 2024 31.8M sh
Operating Cash Flow Q3 2025 · Jul 31, 2025 −$5.92M
Operating Cash Flow Q3 2025 · Jul 31, 2024 −$6.41M
Short Term Investments Q3 2025 · Jul 31, 2025 $14.53M
Short Term Investments Q3 2025 · Oct 31, 2024 $18.65M
Cash And Equivalents Q3 2025 · Jul 31, 2025 $1.5M
Cash And Equivalents Q3 2025 · Oct 31, 2024 $1.27M
Stockholders Equity Q3 2025 · Jul 31, 2025 $16.6M
Stockholders Equity Q3 2025 · Oct 31, 2024 $20M
Current Liabilities Q3 2025 · Jul 31, 2025 $2.07M
Current Liabilities Q3 2025 · Oct 31, 2024 $2.5M
Total Liabilities Q3 2025 · Jul 31, 2025 $2.24M
Total Liabilities Q3 2025 · Oct 31, 2024 $2.7M
Current Assets Q3 2025 · Jul 31, 2025 $17.45M
Current Assets Q3 2025 · Oct 31, 2024 $21.36M
Total Assets Q3 2025 · Jul 31, 2025 $17.65M
Total Assets Q3 2025 · Oct 31, 2024 $21.59M
Eps Diluted Q3 2025 · Jul 31, 2025 −$0.07
Eps Diluted Q3 2025 · Jul 31, 2025 −$0.25
Eps Diluted Q3 2025 · Jul 31, 2024 −$0.10
Eps Diluted Q3 2025 · Jul 31, 2024 −$0.30
Eps Basic Q3 2025 · Jul 31, 2025 −$0.07
Eps Basic Q3 2025 · Jul 31, 2025 −$0.25
Eps Basic Q3 2025 · Jul 31, 2024 −$0.10
Eps Basic Q3 2025 · Jul 31, 2024 −$0.30
Rd Expense Q3 2025 · Jul 31, 2025 $1.06M
Rd Expense Q3 2025 · Jul 31, 2025 $3.93M
Rd Expense Q3 2025 · Jul 31, 2024 $1.93M
Rd Expense Q3 2025 · Jul 31, 2024 $4.92M
Net Income Q3 2025 · Jul 31, 2025 −$2.26M
Net Income Q3 2025 · Jul 31, 2025 −$8.23M
Net Income Q3 2025 · Jul 31, 2024 −$3.28M
Net Income Q3 2025 · Jul 31, 2024 −$9.67M
Operating Income Q3 2025 · Jul 31, 2025 −$2.44M
Operating Income Q3 2025 · Jul 31, 2025 −$8.83M
Operating Income Q3 2025 · Jul 31, 2024 −$3.59M
Operating Income Q3 2025 · Jul 31, 2024 −$10.67M